A natural compound called gentiopicroside effectively lowers inflammation and tissue scarring in a mouse model of pulmonary fibrosis (PF), say…
Articles by Magdalena Kegel
Only a minority of patients with interstitial lung disease (ILD) swiftly receive a correct diagnosis, while more than half are…
A cancer drug in clinical development might be used to treat pulmonary fibrosis (PF), or as a starting point to…
The management of patients with idiopathic pulmonary fibrosis (IPF) and lung cancer should follow the premise “first, do no harm,”…
British regulators have paved the way for people with severe cases of pulmonary fibrosis to gain access to Prometic Life…
Researchers have found another piece in the molecular puzzle of changes leading to pulmonary fibrosis — a cell signaling factor.
Thyroid hormone, delivered through aerosol inhalation, helped to resolve lung scarring in a mouse model of idiopathic pulmonary fibrosis (IPF),…
Patients with idiopathic pulmonary fibrosis (IPF) are likely to experience symptoms for years before their diagnosis, a British study reports.
Autoimmunity may drive idiopathic pulmonary fibrosis (IPF), according to a study that found a link between certain autoantibodies —those that…
Clinical trial results of Patara Pharma’s inhaled therapy candidate PA101 for chronic cough caused by idiopathic pulmonary fibrosis (IPF)…